The Effect of the Breast and Cervical Cancer Prevention and Treatment Act on Medicaid Disenrollment

被引:5
|
作者
Chien, Li-Nien [1 ]
Adams, E. Kathleen [1 ]
机构
[1] Emory Univ, Rollins Sch Publ Hlth, Dept Hlth Policy & Management, Atlanta, GA 30332 USA
关键词
CARE; COVERAGE; INSURANCE; ENROLLMENT;
D O I
10.1016/j.whi.2010.03.004
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Background: The Breast and Cervical Cancer Prevention and Treatment Act (BCCPTA) of 2000 created a new Medicaid option that allowed states to expand coverage to previously uninsured low-income women screened by certain public providers and found in need of treatment for those cancers. States also had the flexibility to allow any provider to screen for this new eligibility category and BCCPTA women were made eligible for all Medicaid services for the duration of their treatment. We have assessed the effect of this new program on the disenrollment patterns of women with breast/cervical cancer versus those with control cancers pre- and post-BCCPTA in Georgia. The post-BCCPTA period analyzed here was one in which Georgia BCCPTA women could self-report that they were in active treatment and, hence, still eligible. Methods: The Georgia Comprehensive Cancer Registry (1999-2004) was linked to Medicaid enrollment files (1998-2005) to identify female Medicaid enrollees aged under 65 and enrolled in Medicaid at or after being diagnosed with breast (n = 2,265), cervical (n = 439) or one of five control cancers (n = 700). The rate of disenrollment (per 100 person-months) was computed for each cancer group pre- versus post-BCCPTA. We employed difference-in-differences analysis to adjust for any temporal changes other than BCCPTA that could affected the disenrollment rate of women with both the treatment (breast/cervical) and control cancers. We used a parametric hazard model with a Weibull distribution to analyze the odds of disenrollment. Results: The unadjusted disenrollment rate declined 50% for women with breast and cervical cancers, whereas it increased over 30% for those with control cancers, pre- versus post-BCCPTA. The direction and magnitude of these results held after adjusting for socio-demographics and area characteristics that could affect disenrollment rates. Conclusion: Georgia BCCPTA has the potential to improve continuity of care for women with breast and cervical cancers because they experience more stable coverage and simpler recertification process under this new eligibility category. Copyright (C) 2010 by the Jacobs Institute of Women's Health. Published by Elsevier Inc.
引用
收藏
页码:266 / 271
页数:6
相关论文
共 50 条
  • [31] The use of vaccines in the prevention and treatment of cervical cancer
    Davidson, EJ
    Kitchener, HC
    Stern, PL
    CLINICAL ONCOLOGY, 2002, 14 (03) : 193 - 200
  • [32] Prevention and Treatment of Cervical Cancer are constantly Changing
    Fehm, Tanja
    Schmidberger, Heinz
    ONKOLOGIE, 2023, 29 (11): : 924 - 926
  • [33] Cervical cancer prevention and treatment in Latin America
    Lopez, Melissa S.
    Baker, Ellen S.
    Maza, Mauricio
    Fontes-Cintra, Georgia
    Lopez, Aldo
    Carvajal, Juan M.
    Nozar, Fernanda
    Fiol, Veronica
    Schmeler, Kathleen M.
    JOURNAL OF SURGICAL ONCOLOGY, 2017, 115 (05) : 615 - 618
  • [34] Epidemiology, prevention and treatment of cervical cancer in the Philippines
    Domingo, Efren J.
    Echo, Ana Victoria V. Dy
    JOURNAL OF GYNECOLOGIC ONCOLOGY, 2009, 20 (01) : 11 - 16
  • [35] Association of Medicaid Expansion Under the Affordable Care Act With Breast Cancer Stage at Diagnosis
    Le Blanc, Justin M.
    Heller, Danielle R.
    Friedrich, Ann
    Lannin, Donald R.
    Park, Tristen S.
    JAMA SURGERY, 2020, 155 (08) : 752 - 758
  • [36] Breast cancer vaccines for treatment and prevention
    Disis, Mary L.
    Cecil, Denise L.
    BREAST CANCER RESEARCH AND TREATMENT, 2022, 191 (03) : 481 - 489
  • [37] SERMs for the treatment and prevention of breast cancer
    Swaby, Ramona F.
    Sharma, Catherine G. N.
    Jordan, V. Craig
    REVIEWS IN ENDOCRINE & METABOLIC DISORDERS, 2007, 8 (03): : 229 - 239
  • [38] Antihormones in prevention and treatment of breast cancer
    Ponzone, Riccardo
    Biglia, Nicoletta
    Jacomuzzi, Maria Elena
    Mariani, Luca
    Dominguez, Annelise
    Sismondi, Piero
    ESTROGENS AND HUMAN DISEASES, 2006, 1089 : 143 - 158
  • [39] Breast cancer vaccines for treatment and prevention
    Mary L. Disis
    Denise L. Cecil
    Breast Cancer Research and Treatment, 2022, 191 : 481 - 489
  • [40] SERMs for the treatment and prevention of breast cancer
    Ramona F. Swaby
    Catherine G. N. Sharma
    V. Craig Jordan
    Reviews in Endocrine and Metabolic Disorders, 2007, 8 : 229 - 239